a valid EU trial number;
a sponsor study number;
an identifiable coded subject;
an identifiable reporter;
a SUSAR;
a suspect investigational medicinal product (including active substance name-code);
a causality assessment.
the sender's (case) safety report unique identifier;
the receive date of the initial information from the primary source;
the receipt date of the most recent information;
the worldwide unique case identification number;
the sender identifier.